Skip to content

Glossary

DAS28

A single figure built from three things: a count of 28 joints, a blood marker of inflammation, and your own rating of your health. The total decides whether treatment needs stepping up.

The DAS28 steers your treatment decisions. It's also the number lifestyle trials keep failing to move, while they improve fitness, tiredness, and how people rate their own health. The score stays where it was.

Quick answerThe DAS28 puts three things into one figure: a count of 28 joints, a blood marker of inflammation, and your own rating of your health. That figure steers treatment. One trial followed a protocol toward a target like that, and remission went from 16 percent to 65 percent.
A combined score hides which of its parts moved, and a DAS28 can fall because joints settled, because a blood marker drifted, or because you rated your health more kindly that day. The single figure doesn't say which. That counts when a change makes you feel better without moving the score, and several trials found just that. One pooled analysis looked at mindfulness in rheumatoid arthritis, where the DAS28-CRP effect was minus 0.44, with a true value somewhere from minus 0.99 to 0.12. It crossed zero, which means chance could explain it.

What the research found.

  • One review pooled trials of following a protocol toward a combined target that included a blood marker of inflammation. More people reached remission than under ordinary care, and the biggest difference was 65 percent against 16 percent. One trial steered by the DAS28 itself reached 38 percent against 21 percent.

    Hock and colleagues, SN Comprehensive Clinical Medicine, 2021

  • One pooled analysis looked at mindfulness in rheumatoid arthritis, across 5 trials and 399 people. The DAS28-CRP effect was minus 0.44, with a true value somewhere from minus 0.99 to 0.12. That range crosses zero, so chance could explain it.

    DiRenzo and colleagues, Current Rheumatology Reports, 2018

  • One trial tested exercise in well-controlled rheumatoid arthritis, where maximal oxygen uptake rose by 3.71 and waist size fell by 2.6 centimeters. The DAS28 showed no clear change at all. So two real gains turned up without the score noticing either of them.

    Bilberg and colleagues, British Journal of Sports Medicine, 2024

  • One trial gave people an anti-inflammatory diet and a control diet in turn, and the DAS28-ESR didn't differ between them on the test the trial planned in advance, at a P value of 0.116. A P value of 0.04 also gets quoted. That one comes from an unplanned test using only the 44 people who finished both periods.

    Vadell and colleagues, American Journal of Clinical Nutrition, 2020

  • One review pooled 71 studies, where low mood and anxiety went with DAS28 remission at an odds ratio of 1.77. The true value sits somewhere from 1.36 to 2.29. Its authors report three things in those patients: lower remission rates, more disability, and higher death rates.

    Sweeney and colleagues, Rheumatology International, 2024

What the number is made of

The DAS28 is a combined score, which is the whole point of it and the source of most confusion about it. It takes a count of tender and swollen joints from a set list of 28, it takes a blood marker of inflammation, and it takes your own rating of your health. Those three inputs get combined into one figure.

Putting three kinds of information into one number was a design choice, and a sensible one. A doctor's exam goes in, a lab result goes in, and your own judgment goes in, because no one of those three tells you enough on its own. Joint counts miss what you feel, blood markers read normal in many people with active disease, and your own rating moves with sleep, with mood, and with everything else in a life.

The cost of that design is simple. A score that fell by half a point doesn't say whether two swollen joints settled, whether a marker drifted down, or whether you rated a better week. Asking which part moved is the more useful question, rather than asking what the total came to.

What it decides

The score's real job is to trigger a decision. One review pooled randomized trials where some patients followed a protocol toward a combined target that included a blood marker of inflammation, and more of them reached remission than under ordinary care. The biggest difference reported was 65 percent against 16 percent.

Other trials in that review pointed in the same direction. One of them was steered by the DAS28 itself and reached 38 percent against 21 percent, while three further trials reported differences of a similar size to each other. So having a target won, and treating by impression didn't.

That's an argument for the method rather than for the number itself. A combined score is a decision rule, and what the review shows is that following a rule beats not following one. This page prints no cut-off values, because we hold no source for them, and a threshold quoted from memory is the kind of number a reader will act on without checking where it came from.

Why lifestyle studies keep missing it

One thing is worth knowing before you read any study of diet or exercise on this site. The DAS28 is a hard outcome to move, and trial after trial improves something real and then leaves the score where it was. That's a consistent finding rather than a run of bad luck.

One pooled analysis looked at mindfulness in rheumatoid arthritis, across 5 trials and 399 people, where the DAS28-CRP effect was minus 0.44 with a true value running from minus 0.99 to 0.12. An exercise trial in well-controlled disease raised maximal oxygen uptake by 3.71 and cut waist size by 2.6 centimeters while the score showed no clear change. A third trial gave people two diets in turn, and the DAS28-ESR didn't differ between them on the test planned in advance, at a P value of 0.116.

The last of those deserves a closer look, because it's widely quoted as showing the opposite. A second result from that trial has a P value of 0.04, from a test that wasn't planned in advance, using only the 44 people who finished both periods. Its title reads as positive while its main test found nothing, which is how a trial that found nothing becomes a citation saying diet lowers disease activity.

What a flat score does and doesn't mean

One trial improved fitness without moving the DAS28, and it still improved fitness. Rheumatoid arthritis comes with raised heart risk, so a gain in maximal oxygen uptake is worth having, and so is a smaller waist. Reading those as a failure reads them against the wrong score, because that score was built for a different purpose.

The reverse caution applies too. The largest review here covers rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis, and it does report one thing, which is that omega-3 reduced the DAS28 in rheumatoid arthritis. So this isn't a claim that nothing outside a prescription pad moves the number. Our record for that review gives no effect size, so this page quotes the direction and not a figure.

The run of flat results argues against one particular reading. Don't read a lifestyle change as a treatment substitute, because something that makes you fitter is worth doing and something that helps you sleep is worth doing, and neither one is evidence of less inflammation. Those are separate claims, and the score is the thing that keeps them separate.

The score in remission and the person who isn't

A number in the remission range describes joints and a blood marker rather than a life, and that's the part that gets lost when a score becomes the goal. The clearest data on the difference comes from sleep. It's worth reading if your own numbers look better than you feel.

One study asked 313 adults with three inflammatory arthritis diagnoses between them about sleep, where the disease was mostly quiet or nearly quiet. Even so, 63.7 percent with rheumatoid arthritis slept badly. It was 61.5 percent in psoriatic arthritis and 66.7 percent in axial spondyloarthritis, and that study looked at people at one moment, so it describes things happening together rather than one causing the other.

Mood belongs in the same section. One review pooled 71 studies, where low mood and anxiety went with DAS28 remission at an odds ratio of 1.77, with a true value running from 1.36 to 2.29. Its authors report lower remission rates, more disability, and higher death rates in those patients. Data that only watches can't separate distress worsening the disease from the disease causing the distress. Either way, mood belongs at a rheumatology visit.

Common misconceptions.

Myth. A falling DAS28 means my disease is settling down.

Reality. It usually does mean that, and the score can't tell you which of its parts moved. Three things feed into one figure, which are joint counts, a blood marker of inflammation, and your own rating of your health, so a fall can come from any of them. Ask which part changed at your next visit, because that's a more useful question than asking what the total is, and the answer changes what should happen next.

Myth. A remission score means I'll feel well.

Reality. It doesn't, and that difference is one of the harder parts of this diagnosis. One study asked 313 adults with inflammatory arthritis about sleep, where the disease was mostly quiet or nearly quiet, and 63.7 percent with rheumatoid arthritis still slept badly, with 61.5 percent in psoriatic arthritis and 66.7 percent in axial spondyloarthritis. So controlling the score is a different achievement from feeling well.

Myth. A trial showed that an anti-inflammatory diet lowers disease activity.

Reality. The trial people quote for that didn't show it, because its own main test found nothing. The DAS28-ESR didn't differ between the two diets on the test planned in advance, at a P value of 0.116. The result people quote has a P value of 0.04, it comes from a test that wasn't planned, and it used only the 44 people who finished both periods of the trial.

Myth. If exercise doesn't lower my score it isn't doing anything.

Reality. One trial ran in well-controlled rheumatoid arthritis, where maximal oxygen uptake rose by 3.71 and waist size fell by 2.6 centimeters while the DAS28 showed no clear change. Those are real gains in heart and lung fitness, in a disease that raises heart risk on its own. The score was built to steer drug treatment rather than to measure everything worth having.

Related terms.

Questions patients ask.

What goes into the DAS28?

Three different kinds of information go into it. The first is a count of tender and swollen joints, taken from a set list of 28 of them, the second is a blood marker of inflammation, and the third is your own rating of your own health. So the score puts together a doctor's exam, a lab result, and your own judgment, which is the design, and it's also why the total can move for three separate reasons.

What score counts as remission?

This site holds no source for the published cut-off values, so this page doesn't print them, and that's on purpose rather than an oversight. A threshold quoted from memory is the kind of number a reader acts on. Your rheumatology team works to specific figures, and asking which ones they use is a fair question.

Why does my score change when nothing feels different?

Because your own rating is only one of its three inputs. A different examiner may count tender joints differently, a blood marker may drift for an unrelated reason, and a rating given on a better morning also moves the total. That's the cost of a combined measure, which is why one score gets read alongside the trend rather than on its own.

Do lifestyle changes lower the DAS28?

Mostly they haven't in trials, with one exception in our sources. A pooled analysis of mindfulness gave minus 0.44, with a true value running from minus 0.99 to 0.12, so it crossed zero. An exercise trial improved fitness without moving the score, and a diet trial's main test found no difference at a P value of 0.116. The largest review does report one thing, which is that omega-3 reduced the DAS28 in rheumatoid arthritis.

Does my score decide my treatment?

In practice it steers it, and the evidence for that is fairly strong. One review pooled randomized trials where following a protocol toward a combined target raised remission rates and beat ordinary care, with the biggest trial reporting 65 percent against 16 percent. So that backs having a target and following it, and it doesn't back any one number as correct.

Why do I see DAS28-CRP and DAS28-ESR?

Because the score can use either blood marker, and the studies on this page use both labels. CRP is a protein the liver makes and it moves within a day or two, while the sedimentation rate measures how fast red cells settle and moves more slowly. This site holds no source comparing the two forms, so how far they differ is a question for your team.

Can my mood affect my score?

One review pooled 71 studies, where low mood and anxiety went with DAS28 remission at an odds ratio of 1.77. Its authors report lower remission rates, more disability, and higher death rates in those patients. Those studies only watched what happened, though, so they can't separate distress worsening the disease from the disease causing the distress in the first place. Either way, raise mood at a rheumatology visit.

References.

  1. Hock E; Martyn-St James M; Wailoo A et al. Treat-to-Target Strategies in Rheumatoid Arthritis: a Systematic Review and Cost-Effectiveness Analysis. SN Comprehensive Clinical Medicine. 2021;3:838-854. 10.1007/s42399-021-00727-4Systematic review of randomised controlled trials
  2. DiRenzo D; Crespo-Bosque M; Gould N et al. Systematic Review and Meta-analysis: Mindfulness-Based Interventions for Rheumatoid Arthritis. Current Rheumatology Reports. 2018;20. 10.1007/s11926-018-0787-4Systematic review and meta-analysis of mindfulness-based interventions in rheumatoid arthritis
  3. Bilberg A; Mannerkorpi K; Borjesson M et al. High-intensity interval training improves cardiovascular and physical health in patients with rheumatoid arthritis: a multicentre randomised controlled trial. British journal of sports medicine. 2024;58:1409-1418. 10.1136/bjsports-2024-108369RCT
  4. Vadell AKE; Bärebring L; Hulander E et al. Anti-inflammatory Diet In Rheumatoid Arthritis (ADIRA)-a randomized, controlled crossover trial indicating effects on disease activity. The American Journal of Clinical Nutrition. 2020;111:1203-1213. 10.1093/ajcn/nqaa019Randomized controlled crossover trial
  5. Sweeney M; Adas M; Cope A et al. Longitudinal effects of affective distress on disease outcomes in rheumatoid arthritis: a meta-analysis and systematic review. Rheumatology International. 2024;44:1421-1433. 10.1007/s00296-024-05574-9Systematic review and meta-analysis of longitudinal observational studies
  6. Polak D; Kolasińska M; Wilk M et al. Sleep disorders in RA, axSpA and PsA are common despite good disease activity control—direct comparison of sleep quality and its risk factors using MDHAQ and PSQI. Clinical Rheumatology. 2026;45:957-965. 10.1007/s10067-025-07892-0Cross-sectional study of 313 adults from the PolNorRHEUMA registry: RA n = 129
  7. Van den Bruel K; Kulyk M; Neerinckx B et al. Nutrition and diet in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: a systematic review. Frontiers in medicine. 2025;12:1655165. 10.3389/fmed.2025.1655165SR

The free guide

Start with Practical Strategies.

It's the handout I give my patients. Practical work on food, daily exposures, and getting started.

No spam · Unsubscribe any time

This page gathers the published research on this subject into one place. The studies behind it were published between 1989 and 2026, and every figure links to the paper it came from. Those studies were peer reviewed. This summary of them was not. Dr. Sarah Luebker is reviewing these pages one at a time and has not reached this one yet, so it carries no medical review date and nothing here is her opinion or her advice to you. Each page gets updated as she reaches it. It is here in the meantime because the science is worth having in one organized place that is easy to find and easy to read. Talk to your own clinician before acting on any of it.